Global estimates of prevalence of chronic painful neuropathy and moderate-to-severe neuropathy among patients with chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis of data from 29 countries between 2000 and 2024
This study provides the first comprehensive global estimate of the prevalence of chronic moderate-to-severe CIPN or painful CIPN, highlighting its significant burden on patients worldwide. The variation in prevalence across geographical regions, chemotherapy regimens, and primary cancers underscores the need for tailored management strategies and further research to address potential disparities.
Authors
- Ryan S. D’Souza (ORCID: https://orcid.org/0000-0002-4601-9837)
- Yeng F Her (ORCID: https://orcid.org/0000-0003-0190-5189)
- Camille Saini (ORCID: https://orcid.org/0000-0003-2459-3034)
- Saba Javed (ORCID: https://orcid.org/0000-0002-1028-8904)
- Larry J. Prokop (ORCID: https://orcid.org/0000-0002-7197-7260)
- Nasir Hussain (ORCID: https://orcid.org/0000-0003-0353-1002)
Institutions
- Rush University Medical Center (US)
- Mayo Clinic (US)
- The University of Texas MD Anderson Cancer Center (US)
- WinnMed (US)
- Mayo Clinic in Florida (US)
- The Ohio State University (US)
Publication Details
- Journal
- Regional Anesthesia & Pain Medicine
- Published
- 2025-01-29
- DOI
- https://doi.org/10.1136/rapm-2024-106229
- Citations
- 24
- Primary Topic
- Cancer Treatment and Pharmacology
- Type
- article
- Field-Weighted Citation Impact
- 25.09